Home/Filings/4/0001225208-22-004393
4//SEC Filing

WANG HUIMIN 4

Accession 0001225208-22-004393

CIK 0001099800other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 8:27 PM ET

Size

8.3 KB

Accession

0001225208-22-004393

Insider Transaction Report

Form 4
Period: 2022-03-08
WANG HUIMIN
CVP, Japan & Intercontinental
Transactions
  • Exercise/Conversion

    Employee Stock Option (Right to Acquire)

    2022-03-083,67540,425 total
    Exercise: $35.20From: 2016-06-12Exp: 2023-05-11Common Stock (3,675 underlying)
  • Sale

    Common Stock

    2022-03-08$107.60/sh3,675$395,43098,026.894 total
  • Exercise/Conversion

    Common Stock

    2022-03-08$35.20/sh+3,675$129,348101,701.894 total
Footnotes (1)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2022.

Documents

1 file

Issuer

Edwards Lifesciences Corp

CIK 0001099800

Entity typeother

Related Parties

1
  • filerCIK 0001204553

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 8:27 PM ET
Size
8.3 KB